It has also been reported that in some estrogen-receptor positive (ER+) breast cancer cells, that the signaling network of ER-MDM2-RB-E2F1 is an essential pathway for estrogen-mediated p53-independent signal transduction. Here, ESR1 is linked to breast carcinoma.